People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RLS Performance Regional LLC | — | Other | Pre-Seed | $729K | $8.4M | 2022 |
| Arena Therapeutics OpCo, Inc. | — | Pharma | Pre-Seed | $600K | $2.8M | 2024 |
David Charles at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Charles on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Kennedy | 1 | 6 |
| Tom Casey | 1 | 4 |
| Russell Leo | 1 | 2 |
| Todd Langevin | 1 | 2 |
| N/A RLS Logistics | 1 | 2 |
| Tim DeLapp | 1 | 1 |
| Zachary Agins | 1 | 1 |
| Mallory Hacker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.